Bank of Nova Scotia
NVO

Bank of Nova Scotia’s Novo Nordisk NVO Stock Holding History

Bank of Nova Scotia’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
+30,000
New +$1.29M ﹤0.01% 830
2026
Q1 		– Sell
-260
Closed -$13.2K – 1171
2025
Q4 		$13.2K Hold
260
– – ﹤0.01% 1100
2025
Q3 		$14.4K Buy
+260
New +$15.2K ﹤0.01% 1043

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of Nova Scotia's NVO Position: Q2 2026 in Review

Bank of Nova Scotia increased its Novo Nordisk (NVO) stake by 5,533% in Q2 2026, buying an estimated $129M and bringing the position to 3,065,015 shares worth $147M. The position accounts for 0.22% of the portfolio, ranked #76.

Bank of Nova Scotia first reported a position in NVO in Q1 2016 and has held it in 11 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bank of Nova Scotia held 3,065,015 shares of Novo Nordisk worth $147M as of Q2 2026.
  • Bank of Nova Scotia bought 3,010,608 Novo Nordisk shares in Q2 2026, an estimated $129M.
  • Novo Nordisk made up 0.22% of Bank of Nova Scotia's portfolio in Q2 2026, its #76 holding.
  • Bank of Nova Scotia first reported a position in Novo Nordisk in Q1 2016 and has held it in 11 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.